Literature DB >> 10941156

Positive surgical margins in neck dissection specimens in patients with head and neck squamous cell carcinoma and the effect of radiotherapy.

L E Smeele1, C R Leemans, J A Langendijk, R Tiwari, B J Slotman, I van Der Waal, G B Snow.   

Abstract

BACKGROUND: To evaluate the outcome after surgery and radiotherapy for extensive nodal disease in patients with primary head and neck cancer.
METHODS: Between 1973 and 1995, 77 from a total of 1398 patients had histopathologic evidence of positive margins in 85 neck dissection specimens for squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx. Postoperative radiotherapy with a curative dose was given to 50 necks. Ipsilateral neck recurrence was defined as the relevant event, and cumulative survival distributions were estimated by the Kaplan-Meier method. Differences between groups were analyzed with the log rank test.
RESULTS: Disease-free survival was 24.9% at 2 years, and disease-specific survival was 33.6% at 2 years. After restriction of the 50 patients who received postoperative curative radiotherapy, the time to neck recurrence was stratified according to irradiation dosage, with 62.5 Gy as the cutoff point. A statistically significant difference was found for patients treated with 62.5 Gy or more, with a regional control rate of 75.6% at 2 years (p <.036).
CONCLUSIONS: The overall outcome after neck dissection with positive surgical margins is poor. Considerable improvement is achieved by postoperative radiotherapy treatment with dosages of 62.5 Gy or more.

Entities:  

Mesh:

Year:  2000        PMID: 10941156     DOI: 10.1002/1097-0347(200009)22:6<559::aid-hed3>3.0.co;2-7

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck.

Authors:  Scott M Langevin; Roslyn A Stone; Clareann H Bunker; Maureen A Lyons-Weiler; William A LaFramboise; Lori Kelly; Raja R Seethala; Jennifer R Grandis; Robert W Sobol; Emanuela Taioli
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

2.  Prognostic significance of Beclin-1 expression in laryngeal squamous cell carcinoma.

Authors:  Li Huang; Shuang Wang; Shi-Sheng Li; Xin-Ming Yang
Journal:  Pathol Oncol Res       Date:  2013-05-19       Impact factor: 3.201

Review 3.  Oral cancer treatment.

Authors:  Terry A Day; Betsy K Davis; M Boyd Gillespie; John K Joe; Megan Kibbey; Bonnie Martin-Harris; Brad Neville; Mary S Richardson; Steven Rosenzweig; Anand K Sharma; Michelle M Smith; Stacy Stewart; Robert K Stuart
Journal:  Curr Treat Options Oncol       Date:  2003-02

4.  Expressions of matrix metalloproteinase-9 (MMP-9), dentin sialophosphoprotein (DSPP), and osteopontin (OPN) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma.

Authors:  Kalu U E Ogbureke; Paul M Weinberger; Stephen W Looney; Li Li; Larry W Fisher
Journal:  Oncotarget       Date:  2012-03

5.  Surgical margins and survival after head and neck cancer surgery.

Authors:  Reina Haque; Richard Contreras; Michael P McNicoll; Evelyn C Eckberg; Diana B Petitti
Journal:  BMC Ear Nose Throat Disord       Date:  2006-02-17

6.  The Efficacy of Low Postoperative Radiation Dose in Patients with Advanced Hypopharyngeal Cancer without High-Risk Factors.

Authors:  Hengmin Tao; Zhong Shen; Zhichao Liu; Yumei Wei
Journal:  Cancer Manag Res       Date:  2020-08-21       Impact factor: 3.989

7.  Update of assessment of survival in head and neck cancer after regional recurrence.

Authors:  Ali Amar; Helma Maria Chedid; Abrão Rapoport; Rogério Aparecido Dedivitis; Claudio Roberto Cernea; Lenine Garcia Brandão; Otavio Alberto Curioni
Journal:  J Oncol       Date:  2012-10-10       Impact factor: 4.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.